These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 7936651)

  • 1. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
    Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J
    Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
    Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
    Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
    Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
    Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
    Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
    Kovar H; Auinger A; Jug G; Müller T; Pillwein K
    Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.
    Davison TS; Yin P; Nie E; Kay C; Arrowsmith CH
    Oncogene; 1998 Aug; 17(5):651-6. PubMed ID: 9704931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.
    Srivastava S; Wang S; Tong YA; Pirollo K; Chang EH
    Oncogene; 1993 Sep; 8(9):2449-56. PubMed ID: 8361758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
    Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in the TP53 gene.
    Eeles RA
    Cancer Surv; 1995; 25():101-24. PubMed ID: 8718514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
    Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
    Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.
    Varley JM; McGown G; Thorncroft M; Cochrane S; Morrison P; Woll P; Kelsey AM; Mitchell EL; Boyle J; Birch JM; Evans DG
    Oncogene; 1996 Jun; 12(11):2437-42. PubMed ID: 8649785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.